Form 15-12G FTAI Aviation Ltd.
Tweet
Share
E-mailUNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 15
Certification and Notice of Termination of Registration under Section 12(g) of
the Securities Exchange Act of 1934 or Suspension of Duty to File Reports Under
Sections 13 and 15(d) of the Securities Exchange Act of 1934.
Commission File Number: 001-37386
FTAI Aviation Ltd.
(Exact name of registrant as specified in its charter)
405 West 13th Street, 3rd Floor, New York, New York 10014
(332) 239-7600
(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)
8.25% Fixed-Rate Reset Series C Cumulative Perpetual Redeemable
Preferred Shares (Title of each class of securities covered by this Form)
Ordinary shares, $0.01 par value per share
9.50% Fixed-Rate Reset Series D Cumulative Perpetual Redeemable Preferred Shares
(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)
Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:
|
Rule 12g-4(a)(1)
|
☐ | |
|
Rule 12g-4(a)(2)
|
☐ | |
|
Rule 12h-3(b)(1)(i)
|
☒ | |
|
Rule 12h-3(b)(1)(ii)
|
☐ | |
|
Rule 15d-6
|
☐ | |
|
Rule 15d-22(b)
|
☐ |
Approximate number of holders of record as of the certification or notice date: 0
Pursuant to the requirements of the Securities Exchange Act of 1934, FTAI Aviation Ltd. has caused this certification/notice to be signed
on its behalf by the undersigned duly authorized person.
|
Date: June 25, 2026
|
|||
|
FTAI Aviation Ltd.
|
|||
|
By:
|
/s/ Nicholas McAleese
|
||
|
Name:
|
Nicholas McAleese
|
||
|
Title:
|
Chief Financial Officer
|
||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Keystone Custom Homes Wins 5 Awards at 2026 Lancaster Parade of Homes
- CobbleStone® Is a Recognized Cloud and Implementation Product Provider Available Through NY OGS (Office of General Services)
- Ernexa Therapeutics Launches CEO Corner to Provide Deeper Insights into Company Progress, Scientific Strategy and Vision for Patients
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
